XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Class A Redeemable Convertible Preferred Shares
Class B Redeemable Convertible Preferred Shares
Class C Redeemable Convertible Preferred Shares
Beginning balance (in shares) at Oct. 31, 2022           266,696 156,036 5,560,607
Beginning balance at Oct. 31, 2022           $ 1,899 $ 1,554 $ 49,665
Beginning balance (in shares) at Oct. 31, 2022   665,767            
Beginning balance at Oct. 31, 2022 $ (76,614) $ 16,390 $ 7,683 $ (1,016) $ (99,671)      
Exercise of stock options (in shares)   1,804            
Exercise of stock options   $ 6 (6)          
Share-based compensation expense 20   20          
Net loss (7,418)       (7,418)      
Ending balance (in shares) at Jan. 31, 2023           266,696 156,036 5,560,607
Ending balance at Jan. 31, 2023           $ 1,899 $ 1,554 $ 49,665
Ending balance (in shares) at Jan. 31, 2023   667,571            
Ending balance at Jan. 31, 2023 (84,012) $ 16,396 7,697 (1,016) (107,089)      
Beginning balance (in shares) at Oct. 31, 2022           266,696 156,036 5,560,607
Beginning balance at Oct. 31, 2022           $ 1,899 $ 1,554 $ 49,665
Beginning balance (in shares) at Oct. 31, 2022   665,767            
Beginning balance at Oct. 31, 2022 (76,614) $ 16,390 7,683 (1,016) (99,671)      
Net loss (17,420)              
Ending balance (in shares) at Jul. 31, 2023           266,696 156,036 5,560,607
Ending balance at Jul. 31, 2023           $ 1,899 $ 1,554 $ 49,665
Ending balance (in shares) at Jul. 31, 2023   701,323            
Ending balance at Jul. 31, 2023 (93,921) $ 16,434 7,752 (1,016) (117,091)      
Beginning balance (in shares) at Oct. 31, 2022           266,696 156,036 5,560,607
Beginning balance at Oct. 31, 2022           $ 1,899 $ 1,554 $ 49,665
Beginning balance (in shares) at Oct. 31, 2022   665,767            
Beginning balance at Oct. 31, 2022 (76,614) $ 16,390 7,683 (1,016) (99,671)      
Ending balance (in shares) at Oct. 31, 2023   23,197,976            
Ending balance at Oct. 31, 2023 72,486 $ 259,373 13,717 (1,016) (199,588)      
Beginning balance (in shares) at Jan. 31, 2023           266,696 156,036 5,560,607
Beginning balance at Jan. 31, 2023           $ 1,899 $ 1,554 $ 49,665
Beginning balance (in shares) at Jan. 31, 2023   667,571            
Beginning balance at Jan. 31, 2023 (84,012) $ 16,396 7,697 (1,016) (107,089)      
Exercise of stock options (in shares)   18,258            
Exercise of stock options 17 $ 27 (10)          
Issuance of common shares upon cashless exercise of options (in shares)   15,494            
Issuance of common shares upon cashless exercise of options   $ 11 (11)          
Share-based compensation expense 39   39          
Net loss (5,282)       (5,282)      
Ending balance (in shares) at Apr. 30, 2023           266,696 156,036 5,560,607
Ending balance at Apr. 30, 2023           $ 1,899 $ 1,554 $ 49,665
Ending balance (in shares) at Apr. 30, 2023   701,323            
Ending balance at Apr. 30, 2023 (89,238) $ 16,434 7,715 (1,016) (112,371)      
Share-based compensation expense 37   37          
Net loss (4,720)       (4,720)      
Ending balance (in shares) at Jul. 31, 2023           266,696 156,036 5,560,607
Ending balance at Jul. 31, 2023           $ 1,899 $ 1,554 $ 49,665
Ending balance (in shares) at Jul. 31, 2023   701,323            
Ending balance at Jul. 31, 2023 (93,921) $ 16,434 7,752 (1,016) (117,091)      
Beginning balance (in shares) at Oct. 31, 2023   23,197,976            
Beginning balance at Oct. 31, 2023 72,486 $ 259,373 13,717 (1,016) (199,588)      
Share-based compensation expense 291   291          
Issuance of warrants in connection with Amended Term Loan 319   319          
Net loss (10,711)       (10,711)      
Ending balance (in shares) at Jan. 31, 2024   23,197,976            
Ending balance at Jan. 31, 2024 62,385 $ 259,373 14,327 (1,016) (210,299)      
Beginning balance (in shares) at Oct. 31, 2023   23,197,976            
Beginning balance at Oct. 31, 2023 $ 72,486 $ 259,373 13,717 (1,016) (199,588)      
Exercise of stock options (in shares) 113,964              
Net loss $ (39,843)              
Ending balance (in shares) at Jul. 31, 2024   44,215,577            
Ending balance at Jul. 31, 2024 230,329 $ 453,479 17,297 (1,016) (239,431)      
Beginning balance (in shares) at Jan. 31, 2024   23,197,976            
Beginning balance at Jan. 31, 2024 62,385 $ 259,373 14,327 (1,016) (210,299)      
Exercise of stock options (in shares)   56,974            
Exercise of stock options 51 $ 207 (156)          
Share-based compensation expense 1,917   1,917          
Issuance of common shares in connection with PIPE Financing, net of issuance costs (in shares)   20,000,000            
Issuance of common shares in connection with PIPE Financing, net of issuance costs 187,614 $ 187,614            
Issuance of common shares upon exercise of warrants (in shares)   520,282            
Issuance of common shares upon exercise of warrants 5,983 $ 6,114 (131)          
Issuance of common shares upon cashless exercise of warrants (in shares)   383,355            
Issuance of common shares upon cashless exercise of warrants   $ 97 (97)          
Net loss (14,984)       (14,984)      
Ending balance (in shares) at Apr. 30, 2024   44,158,587            
Ending balance at Apr. 30, 2024 242,966 $ 453,405 15,860 (1,016) (225,283)      
Exercise of stock options (in shares)   56,990            
Exercise of stock options 51 $ 74 (23)          
Share-based compensation expense 1,460   1,460          
Net loss (14,148)       (14,148)      
Ending balance (in shares) at Jul. 31, 2024   44,215,577            
Ending balance at Jul. 31, 2024 $ 230,329 $ 453,479 $ 17,297 $ (1,016) $ (239,431)